Produkty 197526-33-3

CAS 197526-33-3 występuje w naszej ofercie pod nazwami: Galβ(1–4)GlcNAcβ(1–3)Galβ(1–4)Glc–β–pNP, 4-Nitrophenyl b-lacto-N-neotetraoside, Gal beta(1-4)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP. Oferty producentów: GLPBio, Biosynth, TCI. Dostępne opakowania: 1mg, 5mg, 2mg, -.

Galβ(1–4)GlcNAcβ(1–3)Galβ(1–4)Glc–β–pNP
GLPBio
  • opakowanie: 1mg, 5mg
  • Warianty: 2
od 1069,77
Zobacz produkt
4-Nitrophenyl b-lacto-N-neotetraoside
Biosynth
  • opakowanie: 2mg, 1mg
  • Warianty: 2
Zobacz produkt
Gal beta(1-4)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP
TCI
  • opakowanie: -
  • Warianty: 1
od 110,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

N-[(2S,3S,4R,5S,6S)-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide (CAS 197526-33-3) to związek chemiczny o wzorze sumarycznym C32H48N2O23 i masie molowej 828.7 g/mol. Nazwa systematyczna IUPAC: N-[(2S,3S,4R,5S,6S)-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide. InChIKey: UVJJUCUTPFYZNV-DFCDGZKBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC32H48N2O23
Masa molowa828.7 g/mol
Nazwa IUPACN-[(2S,3S,4R,5S,6S)-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
InChIKeyUVJJUCUTPFYZNV-DFCDGZKBSA-N
SMILESCC(=O)N[C@H]1[C@H]([C@@H]([C@@H](O[C@H]1O[C@H]2[C@H]([C@@H](O[C@H]([C@H]2O)O[C@@H]3[C@@H](O[C@H]([C@H]([C@H]3O)O)OC4=CC=C(C=C4)[N+](=O)[O-])CO)CO)O)CO)O[C@H]5[C@H]([C@H]([C@H]([C@@H](O5)CO)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Gal beta(1-4)GlcNAc beta(1-3)Gal beta(1-4)Glc-beta-pNP, 4-Nitrophenyl b-lacto-N-neotetraoside, 4-Nitrophenyl beta-lacto-N-neotetraoside, Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc-beta-pNP
Izomery (ten sam wzór sumaryczny)
N-[(2S,3S,4R,5R,6S)-2-[(2R,3S,4S,5S,6S)-2-[(2S,3R,4R,5S,6S)-6-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide C32H48N2O23
N-[(2S,3S,4R,5S,6S)-2-[(2S,3S,4S,5S,6S)-2-[(2S,3S,4R,5S,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide C32H48N2O23